Global Genital Warts Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Genital Warts Industry In 2025?

The genital warts market has experienced consistent growth in recent years. It is anticipated to expand from $1.97 billion in 2024 to $2.06 billion in 2025, at a compound annual growth rate (CAGR) of 4.7%. This historical growth can be linked to several factors, including an increased focus on patient-centered care, a heightened emphasis on early detection and treatment, the growing availability of therapies developed for self-target applications, and a rise in both clinical trials and the recurrence of genital warts.

The genital warts market is projected to experience substantial expansion over the upcoming years, with an anticipated growth to $2.52 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.1%. Key drivers contributing to this growth during the forecast period include the uptake of telemedicine and digital health platforms for distant consultations and treatment oversight, an increasing need for potent and cost-effective STI treatments, the rising prominence of loop electrosurgical excision procedures, a surge in demand for interferon alfa-n3 injection, and the expanding availability of various therapies. Significant trends expected throughout this period encompass improvements in diagnostic technologies, a move towards combination therapies, wider adoption of telehealth and virtual consultations, the identification of new therapeutic targets, and market penetration into developing regions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

Which Drivers Are Impacting The Genital Warts Market?

The rising prevalence of sexually transmitted infections (STIs) is a key factor propelling the expansion of the genital warts market in the future. Sexually transmitted infections are diseases primarily passed through sexual contact, including vaginal, anal, and oral sex, and are caused by bacteria, viruses, or parasites. The incidence of these infections is increasing due to heightened sexual activity, inadequate use of protective measures, and limited access to educational and healthcare services. Genital warts are a common STI resulting from specific strains of the human papillomavirus (HPV) and spread through direct skin-to-skin contact during sexual activity. For instance, data from October 2023, provided by the Joint United Nations Programme on HIV/AIDS, a Switzerland-based global program focused on HIV prevention, revealed that in 2021, roughly 38.7 million individuals were infected with HIV, a number that grew to 39.0 million people in 2022, with 1.3 million new infections reported in 2022. Thus, the growing occurrence of sexually transmitted infections (STIs) is driving the growth of the genital warts market.

What Are The Major Segment Types Covered In The Genital Warts Market?

The genital wartsmarket covered in this report is segmented –

1) By Drug Type: Imiquimod; Podophyllin; Podofilox; Trichloroacetic Acid

2) By Treatment: Chemical Treatment; Ablative Treatment; Preventive Treatment; Other Treatments

3) By Gender: Female; Male

4) By End Users: Hospitals; Clinics; Home Care Settings

Subsegments:

1) By Imiquimod: Imiquimod Cream 5%; Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%; Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%; Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%; Trichloroacetic Acid 50-70%

Which Key Trends Are Expected To Influence The Genital Warts Market In The Coming Years?

Key companies active in the genital warts market are creating innovative treatment methods, such as new dermatology drugs, to help patients overcome the difficulties associated with genital warts. Dermatology drugs describe recently developed pharmaceuticals or therapeutic agents specifically intended for treating various skin conditions, including genital warts. For example, in March 2023, Verrica Pharmaceuticals Inc., a US-based dermatology pharmaceutical company, obtained New Chemical Entity (NCE) status for its drug candidate YCANTH. YCANTH is under development for treating genital warts and has finished phase 2 trials. With FDA NCE status, the company now benefits from at least five years of protection against generic competition.

Who Are The Key Multinational Companies Dominating The Genital Warts Market?

Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

How Does The Genital Warts Market Perform Across Key Geographic Regions?

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Genital Warts Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18374&type=smp

Browse Through More Reports Similar to the Global Genital Warts Market 2025, By The Business Research Company

Cryogenic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-equipment-global-market-report

Cryogenic Pump Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-pump-global-market-report

Cryogenic Insulation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-insulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795